Stock Quote
Alfacell Corporation (ACEL.PK) (USA Pink Sheets)
$0.23
2:40pm EST
-8.00%
$0.25
$0.23
10,270
$0.25
$0.23
$0.52
$0.06
0.74
50,486
ACEL.PK
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Sidransky, David | Chairman of the Board | -- |
| Muniz, Charles | President, Chief Financial Officer, Chief Operating Officer, Director | -- |
| Carter, Stephen | Director | -- |
Profile
Alfacell Corporation is a biopharmaceutical company engaged in the discovery and development of a class of therapeutic drugs for the treatment of cancer and other pathological conditions. The Company’s drug discovery and development program consists of therapeutics, which are being developed from... Full Description
Company Address
Alfacell Corporation
300 Atrium Drive
Somerset NJ 08873
P: +1732.6524525
300 Atrium Drive
Somerset NJ 08873
P: +1732.6524525
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Eli Lilly & Co. | $36.81 | +0.22 |
| Merck & Co., Inc. | $36.47 | +0.01 |
| Genentech, Inc. | -- | -- |
| ACEL.PK | Industry | |
|---|---|---|
| P/E(TTM) | -- | 12.80 |
| P/S(TTM) | -- | 29.90 |
| ROI(TTM) | -298.13 | 2.35 |
| ROE(TTM) | -- | 3.59 |
| Consensus Recommendation | |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -- |
| Total Revenue | $0.00M |
| Net Income | $-0.70M |
| EPS | $-0.01 |
